Search CPHI
CHINA PHARMA HOLDINGS, INC.
NYSE · CIK 1106644
Last close0.66
Daily change+0.01 (1.54%)
10 Years gain-99.34%
Dividends TTM0
Dividend yield0.00%
Fundamental Analysis
CPHI · STANDARD
SIC 2834 · Pharmaceutical Preparations · Fiscal year end 1231
Fundamental
22.4Momentum
0.0Acceleration
40.0Confidence
70.0Annual Revenue16
Quarterly Revenue53
Annual CFO16
Balance SheetAvailable
RankingEligible
Score Breakdown
Growth0.0 / 25
Quality12.5 / 25
Capital Efficiency4.0 / 20
Balance Sheet0.9 / 15
Shareholder Economics0.0 / 10
Forward Indicators5.0 / 5
Signals
Gross margin expansionGross margin improved by 49.2682 percentage points.
ROIC expansionROIC improved by 37.7332 percentage points.
Warnings
Operating margin compression · MEDIUMOperating margin compressed by 11.4916 percentage points.
Heavy share dilution · HIGHDiluted share count increased 1142.278%.
Low interest coverage · HIGHInterest coverage is -119.8177x.
Key Metrics
Revenue Growth TTM-18.04%OK
Revenue CAGR 3Y-20.03%OK
Gross Margin5.99%OK
Operating Margin-103.11%OK
FCF Marginn/aMISSING
FCF Growthn/aINSUFFICIENT_HISTORY
ROIC-13.26%OK
Incremental Operating Margin 3Yn/aNOT_MEANINGFUL
Net Debt / CFOn/aNOT_MEANINGFUL
Diluted Share Growth 1Y1,142.28%OK
SBC / Revenuen/aMISSING
SBC / FCFn/aNOT_MEANINGFUL
Financial History
| Period | Revenue | Gross Profit | Operating Income | CFO | FCF | Gross Margin | Op Margin | FCF Margin | ROIC | Shares |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025 FY Dec 31, 2025 | $4.14M | -$131,950.00 | -$3.24M | $148,261.00 | $88,937.00 | -3.18% | -78.16% | 2.15% | -15.95% | n/a |
| 2025 FY Dec 31, 2024 | $4.53M | -$1.99M | -$4.59M | -$406,063.00 | -$444,474.00 | -43.84% | -101.32% | -9.81% | -46.99% | n/a |
| 2024 FY Dec 31, 2023 | $7.01M | -$281,085.00 | -$2.75M | -$699,686.00 | -$711,203.00 | -4.01% | -39.25% | -10.14% | -46.13% | n/a |
| 2023 FY Dec 31, 2022 | $8.10M | -$493,916.00 | -$3.55M | -$409,545.00 | n/a | -6.09% | -43.79% | n/a | -164.01% | n/a |
| 2022 FY Dec 31, 2021 | $9.64M | $349,270.00 | -$2.86M | -$249,838.00 | -$687,893.00 | 3.62% | -29.67% | -7.13% | -33.61% | n/a |
Formula Trace
| Metric | Value | Formula | Status | Source |
|---|---|---|---|---|
| Revenue TTM | $3.71M | sum latest 4 fiscal quarters Revenue | OK | 0001213900-26-090173, 0001213900-25-109203 |
| Revenue Growth TTM | -18.04% | Revenue_TTM / Revenue_TTM_1Y_ago - 1 | OK | 0001213900-26-090173, 0001213900-25-109203 |
| Revenue CAGR 3Y | -20.03% | (Revenue_current / Revenue_3Y_ago)^(1/3) - 1 | OK | 0001213900-26-038521 |
| Revenue CAGR 5Y | -17.53% | (Revenue_current / Revenue_5Y_ago)^(1/5) - 1 | OK | 0001213900-26-038521 |
| Gross Profit CAGR 3Y | n/a | (GrossProfit_current / GrossProfit_3Y_ago)^(1/3) - 1 | INSUFFICIENT_HISTORY | 0001213900-26-038521 |
| Operating Income Growth | n/a | OperatingIncome_current / OperatingIncome_prior_year - 1 | INSUFFICIENT_HISTORY | 0001213900-26-090173, 0001213900-25-109203 |
| FCF Growth | n/a | FCF_current / FCF_prior_year - 1 | INSUFFICIENT_HISTORY | derived |
| Revenue Growth Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Profit Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Operating Income Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| FCF Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Margin | 5.99% | Gross Profit / Revenue | OK | 0001213900-26-090173, 0001213900-25-109203 |
| Operating Margin | -103.11% | Operating Income / Revenue | OK | 0001213900-26-090173, 0001213900-25-109203 |
| ROIC | -13.26% | NOPAT / Average Invested Capital | OK | 0001213900-26-090173, 0001213900-25-109203 |
| Net Debt / CFO | n/a | Net Debt / CFO | NOT_MEANINGFUL | 0001213900-26-090173 |
| Interest Coverage | -119.82x | Operating Income / abs(Interest Expense) | OK | derived |
| Current Ratio | 0.26x | Current Assets / Current Liabilities | OK | derived |
| Cash / Debt | 0.19x | (Cash + Short-term Investments) / Total Debt | OK | 0001213900-26-090173 |